, Inc. (CIIX) Shares Big News Regarding CBD Products and Spin-off

  • Industrial hemp to be removed from the list of controlled substances under U.S. federal law
  • Proposed licensing agreement with VitaMist for exclusive rights in the global Asian market for a new sprayable vitamin and vitamin/CBD product line
  • Company recently announced the appointment of a chief financial officer of CBD Biotech, its CBD spin-off and wholly owned subsidiary, Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, is increasingly enthusiastic about the unique role it is playing within the cannabis industry as laws change globally.

The Agriculture Improvement Act of 2018, also known as the farm bill, recently passed in the United States House of Representatives and the Senate. It was also signed by President Trump ( This bill includes Sen. Majority Leader Mitch McConnell’s Hemp Farming Act, which removes industrial hemp from the list of controlled substances under federal law. This is good news for CIIX, which recognized the opportunities in the U.S. early on. The company has offices located in the U.S. and China, representing a key link between the U.S. and global Chinese community, and it is working on creating additional CBD products in nutrition and cosmetics.

In addition to the changing laws in the United States, CIIX is excited about its new ventures. In a recent press release (, the company announced its intent to enter into a licensing agreement with VitaMist Ltd.

In 1985, VitaMist was awarded the first patent ever for a spray vitamin and has established itself over the years as a recognized brand with over three million individual product sales. Its innovative spray technology, brand recognition, 30 years in the industry and 40+ proprietary vitamin formulas represent a significant addition to CIIX as the company expands product lines globally. “We truly believe,” CIIX CEO Warren Wang stated in a news release, “VitaMist’s innovative and effective delivery system is the future for CBD consumption.”

VitaMist CEO Richard Heineck is equally optimistic regarding the upcoming new sprayable vitamin and vitamin/CBD product line that will be designed exclusively for CIIX and the global Asian market, referring to the proposed licensing agreement as a “grand slam!”  VitaMist’s delivery system and precise dosing methodology and CIIX’s focus on the Asian consumer market all play into making these two companies a promising pair.

Wang expressed excitement at being a part of expanding reach into the global industrial hemp industry. The company’s ties to the Asian consumer market are strong, and, with South Korea becoming the first East Asian country to legalize marijuana for medical purposes, Wang is hopeful that Thailand will soon follow.

The company is one step closer in the process of spinning off its CBD division through the appointment of new leadership. Alex Hamilton has been appointed to the position of chief financial officer of CIIX’s wholly owned subsidiary, CBD Biotechnology, Ltd. ( Hamilton joins Summer Yun, CEO of CBD Biotech. Hamilton has been appointed to oversee the spin-off of the CBD division under the guidance of Wang, freeing CIIX to refocus on its core financial services and media business.

CIIX is a leading financial information website for Chinese-speaking investors throughout the United States, Canada and China. The company is laying the groundwork to capitalize on the growing demand for CBD-based nutrition and health products. The development of new product lines with VitaMist is only a small part of a much larger, globally-focused business plan.

For more information, visit the company’s website at

More from CannabisNewsWire

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

HempWire is at the epicenter of the Cannabis Revolution.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published:

HempWire (HW)
Denver, Colorado
303.498.7722 Office


Select A Month

HempWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 303.498.7722